Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome

• Published in: Science translational medicine 2009-11, Vol.1 (7), p.7ra17-7ra17
• Main Authors: Salehi, A, Faizi, M, Colas, D, Valletta, J, Laguna, J, Takimoto-Kimura, R, Kleschevnikov, A, Wagner, S L, Aisen, P, Shamloo, M, Mobley, W C
• Format: Article
• Language: English
• Subjects: Animals; Disease Models, Animal; Down Syndrome - physiopathology; Down Syndrome - psychology; Learning Disorders; Memory; Mice; Norepinephrine - physiology
• ISSN: 1946-6234; 1946-6242
• DOI: 10.1126/scitranslmed.3000258

Down syndrome (trisomy 21) is the most common cause of mental retardation in children and leads to marked deficits in contextual learning and memory. In rodents, these tasks require the hippocampus and are mediated by several inputs, particularly those originating in the locus coeruleus. These afferents mainly use norepinephrine as a transmitter. To explore the basis for contextual learning defects in Down syndrome, we examined the Ts65Dn mouse model. These mice, which have three copies of a fragment of mouse chromosome 16, exhibited significant deficits in contextual learning together with dysfunction and degeneration of locus coeruleus neurons. However, the postsynaptic targets of innervation remained responsive to noradrenergic receptor agonists. Indeed, despite advanced locus coeruleus degeneration, we were able to reverse contextual learning failure by using a prodrug for norepinephrine called l -threo-3,4-dihydroxyphenylserine, or xamoterol, a β 1 -adrenergic receptor partial agonist. Moreover, an increased gene dosage of App , in the context of Down syndrome, was necessary for locus coeruleus degeneration. Our findings raise the possibility that restoring norepinephrine-mediated neurotransmission could reverse cognitive dysfunction in Down syndrome.